JERUSALEM (JTA) — Israel has signed a deal with the American biotech company Moderna for a potential COVID-19 vaccine.
Israeli Prime Minister Benjamin Netanyahu confirmed the deal on Wednesday during a meeting of the government’s so-called Coronavirus Cabinet, Channel 12 News reported.
Netanyahu said the company claims it will have a vaccine by the middle of next year, and “we hope they will succeed.” Securing a deal to buy the future vaccine “puts us in a very good place in the world.” No details of the deal have been reported.
Forbes reported last week that Moderna has said that its phase 2 trials are underway and the company had enrolled 350 of a total 600 planned participants for the study.
Moderna also said that it was on track to deliver approximately 500 million doses of the vaccine per year and potentially up to 1 billion annually starting in 2021.
Israeli efforts to develop a vaccine are ongoing, Netanyahu said.
The Institute for Biological Research in Nes Ziona, in central Israel, last month completed a successful trial on rodents, according to Channel 12, and will soon begin trials on larger animals.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
